Dice CEO: Energy, T...
Health Care: Drugs
Enzon Pharmaceuticals Inc. (ENZN: NASDAQ)
$6.41 -0.02 | -0.31%
06/01/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 6.41 |
| 52 Week High | 10.46 |
| 52 Week Low | 5.79 |
| Avg. Daily Vol. (Mil) | 0.19 |
| Beta (3 year) | 0.86 |
| Share Related Items | |
| Mkt Cap (Mil) | 309.64 |
| Shares Out (Mil) | 48.31 |
| Float (Mil) | 27.60 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 9.60 |
| Current Ratio | 9.80 |
| LT Debt/ Equity | 0.64 |
| Total Debt / Equity | 0.64 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 7.62 |
| Price/Book | 1.57 |
| Price/Cash Flow | -18.50 |
| Per Share Data | |
| Earnings | -0.44 |
| Sales | 0.84 |
| Book Value | 4.08 |
| Cash Flow | -0.35 |
| Business Summary | |
|---|---|
| Enzon Pharmaceuticals, Inc. is engaged in developing, manufacturing and commercializing important medicines for patients with cancer and other life-threatening conditions. | |
| General Information | |
| 20 Kingsbridge Road
Piscataway, NJ 08854 |
|
| www.enzon.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 72 | |
| CEO: Mr. George W. Hebard, II | |
| Short Interest | |
| Current Month (Mil) | 3.86 |
| Previous Month (Mil) | 4.18 |
| Short Interest Ratio (Days) | 24.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -6.60 |
| Return on Investments | -6.90 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | -39.80 |
| Profit Margin | -54.80 |
Portfolios with ENZN
- Portfolio NameUser Type
- ProSeth Klarman - Baupost Group
- ProCarl Icahn
- UserGFNN Stockdiagnostics 12
- UserVermonty #1
- ProRichard Perry - Perry Capital
- ProMichael Price - MFP Investors
- UserInternational Value Fund
- UserRichard_stocks
- ContributorBarron's Activist Stocks 5-...
- UserASCO 2010 Part 2
Latest ENZN Headlines from TheStreet
- Enzon Pharmaceuticals Inc. (ENZN): Today's Featured Drugs Loser 10.05.11 | 04:10 pm
- Enzon Stock Hits New 52-Week Low (ENZN) 09.30.11 | 03:09 pm
- Enzon Stock Hits New 52-Week Low (ENZN) 09.22.11 | 02:09 pm
- Enzon Pharmaceuticals Inc. Stock Downgraded (ENZN) 08.09.11 | 07:08 am
- Enzon Stock Hits New 52-Week Low (ENZN) 08.04.11 | 11:08 am
- Enzon Stock Hits New 52-Week Low (ENZN) 07.27.11 | 10:07 am
- Enzon Stock Hits New 52-Week Low (ENZN) 06.17.11 | 04:06 pm
- 2 New Stock Picks From Baupost's Klarman 05.16.11 | 06:05 am
- Carl Icahn Bets Big on 23 Stocks 02.16.11 | 06:02 am
- Enzon Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript 05.10.10 | 11:05 pm
Press Releases for ENZN
- Enzon Announces Reduction In Force To Align Operations With Research And Development Activities - Business Wire 09.22.11 | 04:09 pm
- ENZON Names Ana I. Stancic Chief Financial Officer - Business Wire 05.31.11 | 06:05 am
- Enzon Announces Discontinuation Of PEG-SN38 Program In Metastatic Colorectal Carcinoma In Light Of Evolving Standards Of Care - Business Wire 05.19.11 | 06:05 am
- Enzon Reports 1st Quarter 2011 Results - Business Wire 05.06.11 | 08:05 am
- Enzon Presents Data At 2011 AACR Meeting - Business Wire 04.05.11 | 04:04 pm
- Enzon Appoints Richard Mulligan, Ph.D. Vice-Chairman Of The Board; Adopts Majority Vote Standard For Election Of Directors - Business Wire 03.17.11 | 04:03 pm
- Enzon Reports 2010 Results - Business Wire 02.17.11 | 04:02 pm
- Enzon To Release Fourth Quarter 2010 Earnings On Thursday, February 17, 2011; Conference Call And Webcast To Follow - Business Wire 02.10.11 | 07:02 am
- Enzon To Begin Phase 1 Study Of Novel Androgen Receptor MRNA Antagonist In Castration-Resistant Prostate Cancer - Business Wire 01.10.11 | 07:01 am
- Enzon Board Authorizes Share Repurchase Program - Business Wire 12.21.10 | 04:12 pm
Partner Headlines for ENZN
- 5 Biotech Stocks That Could Double - Seeking Alpha 02.01.12 | 07:02 am
- Billionaire Carl Icahn's Top Stock Picks And Portfolio Activity - Seeking Alpha 11.23.11 | 08:11 am
- Tracking Seth Klarman's Baupost Group Holdings - Seeking Alpha 10.18.11 | 09:10 am
- 11 Stocks Carl Icahn And Jim Simons Are Bullish On - Seeking Alpha 09.18.11 | 09:09 am
- 10 Profitable, Small Cap Stocks With Strong Growth And Bullish Trends - Seeking Alpha 08.22.11 | 08:08 am
- Weak Top Line Widens Enzon Loss - Analyst Blog - Zacks 08.09.11 | 10:08 am
- Weak Top Line Widens Enzon Loss - Analyst Blog - Zacks 08.09.11 | 10:08 am
- Seth Klarman's Favorite Stock Picks - Seeking Alpha 07.26.11 | 09:07 am
- Enzon Pharmaceuticals (ENZN) - Bear of the Day - Zacks 06.15.11 | 01:06 am
- Enzon Pharmaceuticals (ENZN) - Bear of the Day - Zacks 06.07.11 | 01:06 am
